An Update on Betrixaban, The Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis

*Department of Vascular and Endovascular Surgery, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran;

†University of Connecticut School of Medicine, Farmington, CT;

‡Department of Pharmacology and Toxicology, School of Medicine, Babol University of Medical Sciences, Babol, Iran;

§Pharmaceutical Sciences Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran; and

¶Vascular Surgery, Department of Vascular and Endovascular Surgery, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.

Correspondence: Pouya Tayebi, MD, Department of Vascular and Endovascular Surgery, Rouhani Hospital, Keshavarz Boulevard, Babol, Mazandaran, Iran 4717647745 (e-mail: [email protected]).

The authors have no conflicts of interest.

Study conception and design: A. A. Moghadamnia, P. Tayebi; Data collection: Y. Daryabari, A. A. Moghadamnia, P. Tayebi; Analysis and interpretation of results: Y. Daryabari, A A. Moghadamnia, P. Tayebi; Draft manuscript preparation: Y. Daryabari, A. A. Moghadamnia, P. Tayebi.

留言 (0)

沒有登入
gif